Global Retirement Partners’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-68
Closed -$2.48K 3681
2024
Q2
$2.48K Hold
68
﹤0.01% 2892
2024
Q1
$2.58K Hold
68
﹤0.01% 2648
2023
Q4
$2.43K Hold
68
﹤0.01% 2598
2023
Q3
$1.96K Hold
68
﹤0.01% 2548
2023
Q2
$2.44K Hold
68
﹤0.01% 2466
2023
Q1
$2.43K Hold
68
﹤0.01% 2429
2022
Q4
$2.29K Hold
68
﹤0.01% 2310
2022
Q3
$2K Hold
68
﹤0.01% 2345
2022
Q2
$2K Hold
68
﹤0.01% 2310
2022
Q1
$2K Buy
+68
New +$2.69K ﹤0.01% 2274
2021
Q4
Sell
-68
Closed -$4K 1910
2021
Q3
$4K Sell
68
-490
-88% -$27.7K ﹤0.01% 1722
2021
Q2
$34K Sell
558
-38
-6% -$2.18K ﹤0.01% 1010
2021
Q1
$34K Buy
+596
New +$37.3K ﹤0.01% 926

Global Retirement Partners's BTEC Position: Q3 2024 in Review

Global Retirement Partners sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q3 2024, closing a stake of 68 shares — an estimated $2.48K sold.

Global Retirement Partners first reported a position in BTEC in Q1 2021 and held it in 13 quarters. The position peaked at $34K in Q2 2021. 0 funds tracked by Wall St. Rank hold BTEC as of Q3 2024.

  • Global Retirement Partners reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q3 2024 after selling out during the quarter.
  • Global Retirement Partners sold 68 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q3 2024, an estimated $2.48K.
  • Global Retirement Partners first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q1 2021 and held it in 13 quarters.
  • Global Retirement Partners's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $34K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q3 2024.

Based on Global Retirement Partners's 13F filing for Q3 2024, filed 16 Oct 2024.